Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
102 pending office actions • 53 art units • 96 examiners • 0 of 102 (0%) have an AI response strategy ready • 138 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 30 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 30 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (2%) |
| §101 + other | 10 (10%) |
| §103 only | 25 (25%) |
| §102 only | 3 (3%) |
| §112 only | 10 (10%) |
| Double-patenting + other | 16 (16%) |
| Multi-statute (no §101) | 36 (35%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JOHNSON, EMILY KATHARINE | 2 | 87.5% | +21.9% |
| RYAN, DOUGLAS CHARLES | 2 | 39.2% | +47.6% |
| ROBINSON, HOPE A | 2 | 67.7% | +43.1% |
| KONOPKA, CATHERINE ANNE | 2 | 58.1% | +65.0% |
| NGUYEN, QUANG | 2 | 38.1% | +52.7% |
| PENNINGTON, KATIE LEIGH | 2 | 29.0% | +58.5% |
| PUTTLITZ, KARL J | 1 | 69.1% | +18.6% |
| SILVA, MICHAEL THOMAS | 1 | 33.6% | +23.1% |
| AGGER, ELIZABETH ROSE | 1 | 95.2% | -0.9% |
| TIWARI, VYOMA SHUBHAM | 1 | 30.2% | +46.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19025487 | SELF-DESTRUCTIVE POLYMORPHIC LATCH FOR ERASING DATA STORED IN VOLATILE MEMORY DURING PHYSICAL ATTACKS | AGGER, ELIZABETH ROSE | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18552486 | PREDICTION OF POST-OPERATIVE PAIN USING HOSVD | STONE, RACHAEL SOJIN | 77d overdue |
| 17772266 | GENE THERAPY VECTORS | PENNINGTON, KATIE LEIGH | 51d overdue |
| 18316064 | DISTRIBUTED LEDGER PLATFORM FOR ELECTRONIC VOTING AND/OR POLLING | LEE, CLAY C | 35d overdue |
| 18191790 | AAV-BASED GENE THERAPY FOR MULTIPLE SCLEROSIS | NGUYEN, QUANG | 9d overdue |
| 16340738 | METHOD AND APPARATUS FOR IMPROVED DETERMINATION OF NODE INFLUENCE IN A NETWORK | LIU, GUOZHEN | 9d overdue |
| 19094455 | SYSTEMS AND METHODS FOR AUTOMATED BUILDING CODE CONFORMANCE | SITTNER, MATTHEW T | 5d overdue |
| 18013954 | EXERGY-BASED LIFE CYCLE ASSESSMENT OF BUILDINGS | YESILDAG, MEHMET | 5d overdue |
| 17788519 | IMMUNOTHERAPY FOR DIRECT REPROGRAMMING OF CANCER CELLS INTO IMMUNE CELLS/ANTIGEN PRESENTING CELLS/DENDRITIC CELLS | DACE DENITO, ALEXANDRA GERALDINE | 9d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17772266 | GENE THERAPY VECTORS | PENNINGTON, KATIE LEIGH | 51d overdue |
| 18191790 | AAV-BASED GENE THERAPY FOR MULTIPLE SCLEROSIS | NGUYEN, QUANG | 9d overdue |
| 18267144 | METHOD FOR PROGRAMMABLE CONTROL OF RNA TRANSCRIPT LEVELS WITH AUTOREGULATED CRISPR-CAS13D | KONOPKA, CATHERINE ANNE | 20d |
| 18840617 | Compositions and Methods for Suppression of Flowering in Sugarcane and Energycane | JOHNSON, EMILY KATHARINE | 39d |
| 19682032 | COMPOSITIONS FOR TARGETING MUSCLE CELLS AND USES THEREOF | PUTTLITZ, KARL J | — |
| 19324860 | VEHICLE SECURITY ANALYSIS PLATFORM | SILVA, MICHAEL THOMAS | — |
| 18870030 | CELL-FREE DNA CONCENTRATION IN HYPOTHERMIC MACHINE PERFUSATE AS A RAPID MARKER FOR KIDNEY GRAFT QUALITY | TIWARI, VYOMA SHUBHAM | — |
| 18706881 | IMPROVED GENETIC TRANSFORMATION BY IMPROVING DE-NOVO SHOOT REGENERATION IN ADULT PLANTS AND DURING IN-VITRO TISSUE CULTURE | JOHNSON, EMILY KATHARINE | — |
| Art Unit | Apps |
|---|---|
| 1662 | 5 |
| 1634 | 4 |
| 1635 | 4 |
| 1631 | 4 |
| 1643 | 3 |
| 1645 | 3 |
| 1636 | 3 |
| 1633 | 2 |
| 1637 | 2 |
| 1652 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19682032 | COMPOSITIONS FOR TARGETING MUSCLE CELLS AND USES THEREOF | PUTTLITZ, KARL J | 1646 | §103§112 | Non-Final OA | — | Pending | May 19, 2026 |
| 19324860 | VEHICLE SECURITY ANALYSIS PLATFORM | SILVA, MICHAEL THOMAS | 3663 | §103§112 | Non-Final OA | — | Pending | Sep 10, 2025 |
| 19025487 | SELF-DESTRUCTIVE POLYMORPHIC LATCH FOR ERASING DATA STORED IN VOLATILE MEMORY DURING PHYSICAL ATTACKS | AGGER, ELIZABETH ROSE | — | §103 | Non-Final OA | — | Pending | Jan 16, 2025 |
| 18870030 | CELL-FREE DNA CONCENTRATION IN HYPOTHERMIC MACHINE PERFUSATE AS A RAPID MARKER FOR KIDNEY GRAFT QUALITY | TIWARI, VYOMA SHUBHAM | — | §103§112 | Non-Final OA | — | Pending | Nov 27, 2024 |
| 18865936 | APPARATUS AND METHOD FOR DETERMINING STIMULATION PARAMETERS FOR DEEP BRAIN STIMULATION (DBS) | WEHRHEIM, LINDSEY GAIL | — | §102 | Non-Final OA | — | Pending | Nov 14, 2024 |
| 18912748 | MATERIALS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF CANCER | SKOKO III, JOHN JOSEPH | 1643 | §103§112DP | Non-Final OA | — | Pending | Oct 11, 2024 |
| 18884901 | SITE-SPECIFIC INTEGRATING RECOMBINANT AAV VECTORS FOR GENE THERAPY AND IMPROVED PRODUCTION METHODS | JOHNSON, ALLISON MARIE | — | §102§112 | Non-Final OA | — | Pending | Sep 13, 2024 |
| 18840617 | Compositions and Methods for Suppression of Flowering in Sugarcane and Energycane | JOHNSON, EMILY KATHARINE | 1662 | §103§112 | Final Rejection | 39d | Pending | Aug 22, 2024 |
| 18728925 | PROCESS FOR SYNTHESIS OF GALBULIMIMA ALKALOID 18 AND COMPOUNDS USEFUL AS OPIOID RECEPTOR ANTAGONISTS AND AGONISTS | YOUNGBLOOD, WILLIAM JUSTIN | — | §112 | Non-Final OA | — | Pending | Jul 15, 2024 |
| 18717509 | BCL-XL/BCL-2 DUAL DEGRADERS FOR TREATMENT OF CANCERS | AULAKH, CHARANJIT | — | §112 | Non-Final OA | — | Pending | Jun 07, 2024 |
| 18716013 | METHOD, APPARATUS, AND SYSTEM FOR REMOVAL OF LESIONS | TEMPLETON, MARINA DELANEY | 3794 | §102§103 | Non-Final OA | — | Pending | Jun 03, 2024 |
| 18707248 | Controlling Citrus Huanglongbing (HLB) by Mitigating Cell Death of the Phloem Tissues Caused by Candidatus Liberibacter Asiaticus (CLas) By Suppressing Reactive Oxygen Species (ROS) | MEYER, GEORGE WILLIAM | 1662 | §103§112 | Non-Final OA | — | Pending | May 03, 2024 |
| 18706881 | IMPROVED GENETIC TRANSFORMATION BY IMPROVING DE-NOVO SHOOT REGENERATION IN ADULT PLANTS AND DURING IN-VITRO TISSUE CULTURE | JOHNSON, EMILY KATHARINE | 1662 | §102§103§112 | Final Rejection | — | Pending | May 02, 2024 |
| 18706176 | AAV-MEDIATED THERAPIES FOR VISION LOSS ASSOCIATED WITH FRIEDREICH’S ATAXIA | LARA, CAROLINE MONSERRAT | 1633 | §103DP | Non-Final OA | — | Pending | Apr 30, 2024 |
| 18704712 | SMALL MOLECULE DEGRADATION METHODS FOR TREATING ALS/FTD | ROCHELLE, CIERRA MARIE | — | §112DP | Non-Final OA | — | Pending | Apr 25, 2024 |
| 18623087 | CYANOBACTERIAL HOSTS AND METHODS FOR PRODUCING CHEMICALS | MORGAN, BAILEY MICHELLE | 1645 | §103DP | Non-Final OA | — | Pending | Apr 01, 2024 |
| 18696085 | GENE THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY | RAHMAN, MASUDUR | — | §102§103 | Non-Final OA | — | Pending | Mar 27, 2024 |
| 18692438 | AAVRH74 PARTICLES FOR GENE THERAPY OF MUSCLE DISEASE | RYAN, DOUGLAS CHARLES | — | §101§102§103 | Non-Final OA | — | Pending | Mar 15, 2024 |
| 18692493 | AAV PARTICLES WITH MODIFIED INVERTED TERMINAL REPEATS FOR ENHANCED GENE EXPRESSION IN MUSCLE | SMALL, KATHERINE R | 1633 | §102§103 | Non-Final OA | — | Pending | Mar 15, 2024 |
| 18595698 | DYNAMIC REFINEMENT OF HARDWARE ASSERTION CHECKERS | LIN, ARIC | — | §102§103 | Non-Final OA | — | Pending | Mar 05, 2024 |
| 18686633 | RADIATION COMPATIBLE EXPANDER FOR BREAST RECONSTRUCTION | FLORES, ADRIAN | 3774 | §102§103 | Non-Final OA | — | Pending | Feb 26, 2024 |
| 18293040 | ENGINEERING AAV VECTORS WITH IMPROVED CNS TARGETING | BARRON, SEAN C | 1653 | §103 | Non-Final OA | — | Pending | Jan 29, 2024 |
| 18290734 | CONTROLLING PRO-INFLAMMATORY MACROPHAGE PHENOTYPE THROUGH BIOFUNCTIONAL HYDROGEL DESIGN | BEANE, RANDALL L | — | §103§112 | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18288301 | SYNTHETIC AAV VECTORS FOR REPEATED DELIVERY OF THERAPEUTIC GENES | KNIGHT, TERESA E | 1634 | §102 | Non-Final OA | — | Pending | Oct 25, 2023 |
| 18287690 | MULTIFACETED APPROACH TO NOVEL INTERLEUKIN-6 INHIBITORS | BARSKY, JARED | 1628 | §102§112DP | Non-Final OA | — | Pending | Oct 20, 2023 |
| 18287711 | AAVRH74 VECTORS FOR GENE THERAPY OF MUSCULAR DYSTROPHIES | SULLIVAN, STEPHANIE LAUREN | 1635 | §103§112DP | Non-Final OA | — | Pending | Oct 20, 2023 |
| 18287368 | AGENTS FOR MANUFACTURE OF CO-ASSEMBLING PEPTIDES | JAUHARI, SACHI | 1654 | §103§112 | Non-Final OA | — | Pending | Oct 18, 2023 |
| 18484830 | WIRELESS CHARGING AND NEAR-FIELD COMMUNICATION (NFC) INTEGRATION | FANTU, YALKEW | — | §103 | Non-Final OA | — | Pending | Oct 11, 2023 |
| 18286450 | EXOSOME GENE THERAPY FOR TREATING INNER EAR DISEASE | LIPPOLIS, ALEXANDRA ROSE | 1637 | §102§103§112 | Non-Final OA | — | Pending | Oct 11, 2023 |
| 18552486 | PREDICTION OF POST-OPERATIVE PAIN USING HOSVD | STONE, RACHAEL SOJIN | 3681 | §101§103 | Non-Final OA | 77d overdue | Pending | Sep 26, 2023 |
| 18236078 | PROTEIN-PEG INTERACTIONS THAT REDIRECT THE THERMAL UNFOLDING PATHWAY OF PEGYLATED HUMAN GALECTIN-3C | ROBINSON, HOPE A | 1652 | §102§103§112 | Non-Final OA | — | Pending | Aug 21, 2023 |
| 18031505 | SELF-ASSEMBLING URICASE FUSION PEPTIDES | MOEHLMAN, ANDREW TERRY | 1655 | §103§112 | Final Rejection | 41d | Pending | Aug 18, 2023 |
| 18451509 | SPATIO-TEMPORAL INTELLIGENT DIGITAL MEMORY SYSTEMS AND METHODS | COLEMAN, PAUL | 2126 | §103§112 | Final Rejection | — | Pending | Aug 17, 2023 |
| 18271769 | SYNERGISTIC MIXTURES COMPRISING PYRETHRUM FOR ARTHROPOD TOXICITY AND REPELLENCY | MELLER, MICHAEL V | 1655 | §101§102§103 | Final Rejection | — | Pending | Jul 11, 2023 |
| 18271584 | ANTICANCER COMPOUNDS AND USES THEREOF | BENAVIDES, JENNIFER ANN | 1675 | §112 | Final Rejection | — | Pending | Jul 10, 2023 |
| 18268280 | CREATE HUANGLONGBING TOLERANCE BY SILENCING A CITRUS NEGATIVE IMMUNE REGULATOR | DELEO, VICTORIA LYNN | 1662 | §102§103 | Non-Final OA | — | Pending | Jun 19, 2023 |
| 18267144 | METHOD FOR PROGRAMMABLE CONTROL OF RNA TRANSCRIPT LEVELS WITH AUTOREGULATED CRISPR-CAS13D | KONOPKA, CATHERINE ANNE | 1635 | §103§112 | Final Rejection | 20d | Pending | Jun 14, 2023 |
| 18257237 | DIPHENHYDRAMINE AND LACTOFERRIN FOR PREVENTION AND TREATMENT OF COVID-19 | COFFA, SERGIO | 1658 | §103DP | Final Rejection | 56d | Pending | Jun 13, 2023 |
| 18327296 | FUNCTIONAL VERIFICATION FLOW OF OBFUSCATED DESIGNS FOR CIRCUITS | NGUYEN, NHA T | 2851 | §103 | Final Rejection | — | Pending | Jun 01, 2023 |
| 18038321 | USE OF INSULIN-LIKE GROWTH FACTORS WITH GAMMA-CHAIN CYTOKINES TO INDUCE HOMEOSTATIC PROLIFERATION OF LYMPHOCYTES | SULLIVAN, DENNIS JOHN | 1642 | §103 | Non-Final OA | — | Pending | May 23, 2023 |
| 18037364 | MULTIFUNCTION MICROFLUIDIC OPTRODE | ROANE, AARON F | 3796 | §102 | Non-Final OA | — | Pending | May 17, 2023 |
| 18253010 | Modified Insecticidal Proteins | MEADOWS, CHRISTINA L | 1663 | §112 | Final Rejection | 35d overdue | Pending | May 15, 2023 |
| 18316064 | DISTRIBUTED LEDGER PLATFORM FOR ELECTRONIC VOTING AND/OR POLLING | LEE, CLAY C | 3699 | §101§103 | Final Rejection | 35d overdue | Pending | May 11, 2023 |
| 18314773 | USE OF AAV-EXPRESSED M013 PROTEIN AS AN ANTI-INFLAMMATORY THERAPEUTIC | NGUYEN, QUANG | 1631 | §103§112 | Non-Final OA | — | Pending | May 09, 2023 |
| 18305971 | DETECTING AUDIO DEEPFAKES THROUGH ACOUSTIC PROSODIC MODELING | BECKER, TYLER JUSTIN | 2657 | §103 | Final Rejection | 28d | Pending | Apr 24, 2023 |
| 18032648 | METHOD FOR TREATING ALS/FTD THROUGH DEGRADATION OF RNA REPEAT EXPANSION | TOWNSLEY, SARA ELIZABETH | 1629 | §112 | Final Rejection | 15d overdue | Pending | Apr 19, 2023 |
| 18191790 | AAV-BASED GENE THERAPY FOR MULTIPLE SCLEROSIS | NGUYEN, QUANG | 1631 | §103§112 | Final Rejection | 9d overdue | Pending | Mar 28, 2023 |
| 18028937 | CANNABIS PLANT DERIVED EXTRACELLULAR VESICLES AND THERAPEUTIC METHODS USING THE SAME | LEE, SIN J | 1613 | §103§112 | Final Rejection | — | Pending | Mar 28, 2023 |
| 18026389 | COMPOSITIONS AND METHODS FOR MODULATION OF BACTERIAL GENE EXPRESSION | RYAN, DOUGLAS CHARLES | 1635 | §112 | Non-Final OA | — | Pending | Mar 15, 2023 |
| 18178819 | CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF | DUFFY, PATRICIA ANN | 1645 | §112 | Final Rejection | — | Pending | Mar 06, 2023 |
| 18042424 | SILK PARTICLES ENCAPSULATING OXYGEN CARRIERS AS ARTIFICIAL BLOOD SUBSTITUTE | JANOSKO, CHASITY PAIGE | 1613 | §103 | Non-Final OA | — | Pending | Feb 21, 2023 |
| 18017726 | IMPROVED AAV-MEDIATED X-LINKED RETINOSCHISIS THERAPIES | ALLEN, MICHAEL D | 1671 | §103 | Final Rejection | — | Pending | Jan 24, 2023 |
| 17924539 | DISEASE CORRECTION BY DELIVERY OF AAV8 VECTORS EXPRESSING CODON OPTIMIZED NAGLU | PENNINGTON, KATIE LEIGH | 1634 | §103 | Final Rejection | — | Pending | Nov 10, 2022 |
| 17919052 | ENHANCED EFFECTS OF GENE-IMMUNOTHERAPY AND IMMUNOSUPPRESSANTS IN MULTIPLE SCLEROSIS | SHIBUYA, MARK LANCE | 1631 | §103Other | Non-Final OA | 3d overdue | Pending | Oct 14, 2022 |
| 18045873 | AAV VARIANTS WITH HOST ANTIBODY ESCAPE CAPABILITIES AND ALTERED TISSUE TARGETING PROPERTIES | KONOPKA, CATHERINE ANNE | 1635 | §103DP | Final Rejection | — | Pending | Oct 12, 2022 |
| 18045563 | AUTOMATED CYBERATTACK DETECTION USING TIME-SEQUENTIAL DATA, EXPLAINABLE MACHINE LEARNING, AND/OR ENSEMBLE BOOSTING FRAMEWORKS | LIN, SHERMAN L | 2447 | §103 | Non-Final OA | 22d | Pending | Oct 11, 2022 |
| 17918052 | SHEATH/CATHETER SECURING DEVICE | ALLEN, ROBERT F | 3783 | §102§103 | Non-Final OA | 27d | Pending | Oct 10, 2022 |
| 17911026 | METHODS, DEVICES, AND COMPOSITIONS FOR LESION REPAIR AND PREVENTION | NGUYEN, NGOC-ANH THI | 1615 | §103 | Non-Final OA | — | Pending | Sep 12, 2022 |
| 17910327 | AFFINITY MATURED AND HUMANIZED BINDING DOMAINS TARGETING ROR2 | BRISTOL, LYNN ANNE | 1643 | §112 | Non-Final OA | — | Pending | Sep 08, 2022 |
| 17800687 | Multilamellar RNA Nanoparticles and Methods of Sensitizing Tumors to Treatment with Immune Checkpoint Inhibitors | ZOU, NIANXIANG | 1671 | §103§112DP | Non-Final OA | 19d overdue | Pending | Aug 18, 2022 |
| 17788519 | IMMUNOTHERAPY FOR DIRECT REPROGRAMMING OF CANCER CELLS INTO IMMUNE CELLS/ANTIGEN PRESENTING CELLS/DENDRITIC CELLS | DACE DENITO, ALEXANDRA GERALDINE | 1636 | §103§112Other | Non-Final OA | 9d | Pending | Jun 23, 2022 |
| 17772266 | GENE THERAPY VECTORS | PENNINGTON, KATIE LEIGH | 1634 | §102§103§112 | Non-Final OA | 51d overdue | Pending | Apr 27, 2022 |
| 17762543 | VACCINE THERAPY FOR RAN PROTEIN DISEASES | WANG, CHANG YU | 1675 | §102DP | Non-Final OA | 35d | Pending | Mar 22, 2022 |
| 17635631 | ARYL AND PYRIDYL AMIDE PESTICIDES AND COMPOSITIONS THEREOF | CHENG, KAREN | 1623 | §102§103§112 | Non-Final OA | 26d | Pending | Feb 15, 2022 |
| 17630843 | SYNERGISTIC MIXTURES FOR ARTHROPOD TOXICITY AND REPELLENCY | PURDY, KYLE A | 1611 | §103§112 | Final Rejection | — | Pending | Jan 27, 2022 |
| 17584505 | MACHINE LEARNING DEVELOPMENT USING SUFFICIENTLY-LABELED DATA | DIEP, DUY T | 2123 | §103 | Final Rejection | 27d | Pending | Jan 26, 2022 |
| 17575762 | CHIMERIC ANTIGEN RECEPTOR COMPRISING INTERLEUKIN-15 INTRACELLULAR DOMAIN AND USES THEREOF | DUFFY, BRADLEY | 1643 | §103 | Final Rejection | — | Pending | Jan 14, 2022 |
| 17621029 | STRUCTURALLY DEFINED SIRNA-DUAL VARIABLE DOMAIN IMMUNOGLOBULIN CONJUGATES | TRAN, CHRISTINA L | 1637 | §112 | Non-Final OA | — | Pending | Dec 20, 2021 |
| 17540121 | RAAV-GUANYLATE CYCLASE COMPOSITIONS AND METHODS FOR TREATING LEBER'S CONGENITAL AMAUROSIS-1 (LCA1) | MOLOYE, TITILAYO | 1632 | §112DP | Non-Final OA | 21d | Pending | Dec 01, 2021 |
| 17603302 | MODIFIED AAV VECTORS THAT DAMPEN THE HUMORAL IMMUNE RESPONSE | WANG, RUIXUE | 1672 | §103 | Non-Final OA | 31d overdue | Pending | Oct 12, 2021 |
| 17428749 | METHODS FOR TARGETED TREATMENT AND PREDICTION OF PATIENT SURVIVAL IN CANCER | HAMMELL, NEIL P | 1681 | §101§103§112 | Non-Final OA | — | Pending | Aug 05, 2021 |
| 17228298 | ENGINEERED RECEPTOR/LIGAND SYSTEM FOR DELIVERY OF THERAPEUTIC AGENTS | ZAHORIK, AMANDA MARY | 1636 | §103§112 | Final Rejection | — | Pending | Apr 12, 2021 |
| 17272203 | ADENO-ASSOCIATED VIRAL VECTORS FOR THE TREATMENT OF BEST DISEASE | BATES, KEENAN ALEXANDER | 1631 | §102§103§112 | Non-Final OA | — | Pending | Feb 26, 2021 |
| 16972740 | AAV CARDIAC GENE THERAPY FOR CARDIOMYOPATHY | SU-TOBON, QIWEN NMN | 1636 | §103DP | Non-Final OA | — | Pending | Dec 07, 2020 |
| 16340738 | METHOD AND APPARATUS FOR IMPROVED DETERMINATION OF NODE INFLUENCE IN A NETWORK | LIU, GUOZHEN | 1686 | §101§103§112Other | Final Rejection | 9d overdue | Pending | Apr 10, 2019 |
| 19220933 | METHODS AND COMPOSITIONS FOR PLANT PATHOGEN RESISTANCE IN PLANTS | ZHONG, WAYNESHAOBIN | — | §112 | Non-Final OA | — | Pending | May 28, 2025 |
| 19094455 | SYSTEMS AND METHODS FOR AUTOMATED BUILDING CODE CONFORMANCE | SITTNER, MATTHEW T | 3629 | §101§103§112 | Final Rejection | 5d overdue | Pending | Mar 28, 2025 |
| 19100617 | COMPOSITIONS, KITS, METHODS, AND METHODS OF ADMINISTRATION RELATING TO EDWARDSIELLA PISCICIDA VACCINE AND/OR ANTIGEN DELIVERY VECTOR SYSTEMS | HAUK TEODORO, PRICILA NMN | 1645 | §102§103 | Non-Final OA | — | Pending | Feb 03, 2025 |
| 19037772 | LEARNING MEMORY SYSTEMS AND METHODS | DARE, RYAN A | 2132 | §101 | Final Rejection | — | Pending | Jan 27, 2025 |
| 19020470 | AI-ASSISTED CODE COMPLIANCE CHECKING FOR BUILDING AND LAND DEVELOPMENT | BEARD, CHARLES LLOYD | — | §103Other | Non-Final OA | — | Pending | Jan 14, 2025 |
| 18949297 | METHODS AND COMPOSITIONS FOR MINIMIZING X-RAY SCATTERING ARTIFACTS | VETERE, ROBERT A | 1712 | §102§103§112DP | Final Rejection | 30d | Pending | Nov 15, 2024 |
| 18701456 | Insect Toxin Delivery Mediated by a Begomovirus Coat Protein | CHATTERJEE, JAYANTA | 1662 | §103DP | Final Rejection | 33d | Pending | Apr 15, 2024 |
| 18691666 | CELLULAR THERAPY TO SUPPRESS IMMUNE RESPONSE | METCALF, MATTHEW CURRAN | — | §102§103 | Non-Final OA | — | Pending | Mar 13, 2024 |
| 18689470 | NOVEL COMPOUNDS FOR MANAGEMENT OF BACTERIAL SPOT DISEASE IN TOMATO | HEASLEY, MEGHAN CHRISTINE | 1626 | §103 | Final Rejection | — | Pending | Mar 06, 2024 |
| 18682048 | VIRTUAL BUILDING CONSTRUCTION INSPECTION FOR PERMITTING | EDMONDS, DONALD J | 3629 | §101 | Non-Final OA | — | Pending | Feb 07, 2024 |
| 18293521 | SYSTEMS AND METHODS FOR AUTOMATING THE CONSTRUCTION AND ORGANIZATION OF A TAXONOMY | BHUYAN, MOHAMMAD SOLAIMAN | 2168 | §101§103 | Final Rejection | 22d | Pending | Jan 30, 2024 |
| 18580480 | HYBRID ELECTROMECHANICAL TRANSFORMER | KLIMOWICZ, WILLIAM JOSEPH | — | §102§103 | Non-Final OA | — | Pending | Jan 18, 2024 |
| 18556967 | SEMI-CLOSED CYCLE AERO ENGINE WITH CONTRAIL SUPPRESSION | MEILLER, SEAN V | 3741 | §103 | Final Rejection | 49d | Pending | Oct 24, 2023 |
| 18555956 | ENZYMATICALLY-CLEAVABLE GLYCIDYL METHACRYLATE HYALURONIC ACID | ROBINSON, HOPE A | 1652 | §103 | Non-Final OA | — | Pending | Oct 18, 2023 |
| 18267184 | HIGH DIMENSIONAL AND ULTRAHIGH DIMENSIONAL DATA ANALYSIS WITH KERNEL NEURAL NETWORKS | COVINGTON, AMANDA R | 3686 | §101§103 | Non-Final OA | — | Pending | Jun 14, 2023 |
| 18204602 | SELF-ASSEMBLED THIN CARBON NANOTUBE FILMS USING AMPHIPHILIC PENDANT POLYMER DISPERSANTS | NGUYEN, HAIDUNG D | 1761 | §102§103 | Final Rejection | — | Pending | Jun 01, 2023 |
| 18026300 | COMPOSITIONS INCLUDING MAGNETIC NANOPARTICLES AND METHODS OF USING AND MAKING THE SAME | SCHLIENTZ, LEAH H | 1618 | §103 | Final Rejection | — | Pending | Mar 14, 2023 |
| 18013954 | EXERGY-BASED LIFE CYCLE ASSESSMENT OF BUILDINGS | YESILDAG, MEHMET | 3624 | §101§102 | Final Rejection | 5d overdue | Pending | Dec 30, 2022 |
| 18013359 | IN-SITU SERVO-HYDRAULIC BIO-MANIPULATOR | HUANG, MICKEY NMN | 1758 | §103 | Final Rejection | — | Pending | Dec 28, 2022 |
| 17925776 | BENZOYLHYDRAZIDE-DERIVED HDAC DEGRADERS AS THERAPEUTICS FOR TREATING CANCER AND OTHER HUMAN DISEASES | SCHMIDT, IZABELA MARIA | 1621 | §103DP | Final Rejection | — | Pending | Nov 16, 2022 |
| 17912690 | GENE THERAPY FOR COCKAYNE SYNDROME | SINGH, ANOOP KUMAR | 1632 | §102§103§112 | Final Rejection | — | Pending | Sep 19, 2022 |
| 17906508 | DEUTERIUM MAGNETIC RESONANCE IMAGING | WESTERBERG, NISSA M | 1618 | §103§112 | Non-Final OA | — | Pending | Sep 16, 2022 |
| 17802686 | COMPOSITIONS, METHODS, KITS, AND SYSTEMS RELATING TO CHARGE-NEUTRAL MICROGELS FOR 3D CELL CULTURE AND PRINTING | KASAYAN, KATRIEL BARCELLANO | 1634 | §103 | Non-Final OA | — | Pending | Aug 26, 2022 |
| 17775206 | CRISPR COMPLEX-BASED DETECTION SYSTEM AND METHOD | SALVOZA, M FRANCO G | 1672 | §103DP | Non-Final OA | — | Pending | May 06, 2022 |
| 17727519 | Method of Treating Colorectal Cancers Using a PKC Inhibitor | LEE, WILLIAM Y | 1623 | §103 | Final Rejection | 29d | Pending | Apr 22, 2022 |
| 17565972 | CELLULAR MICRO-MASONRY SYSTEM | NGUYEN, HENRY H | 1758 | §103 | Final Rejection | 18d overdue | Pending | Dec 30, 2021 |
| 17286151 | MAGNETICALLY RESPONSIVE COMPOSITE MICROPARTICLES FOR TRIGGERED DELIVERY OF BIOLOGICALLY ACTIVE AGENTS | HOERNER, PAUL ELLSWORTH | 1611 | §103 | Non-Final OA | — | Pending | Apr 16, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial